« Previous
Next »
The American Journal of Medicine
Volume 123, Issue 4
, Pages
322-328.e2
, April 2010
Long-acting Beta-Agonists with and without Inhaled Corticosteroids and Catastrophic Asthma Events
-
Effect of long-acting β-agonists on asthma intubations and deaths. 1. Long-acting β-agonists with variable inhaled corticosteroids compared with placebo. 2. Long-acting β-agonists with concomitant inh
Effect of long-acting β-agonists on asthma intubations and deaths. 1. Long-acting β-agonists with variable inhaled corticosteroids compared with placebo. 2. Long-acting β-agonists with concomitant inhaled corticosteroids compared with inhaled corticosteroids alone. n
=
number of participants with at least 1 asthma intubation or death; N
=
number of participants; SMART
=
Salmeterol Multi-center Asthma Research Trial; GSK
=
GlaxoSmithKline; OR = odds ratio; CI
=
confidence interval.
Funding: Santa Clara Valley Medical Center, San Jose, Calif.
Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript. None of the authors have had any relationships with a pharmaceutical company that manufactures a β-agonist or other respiratory medications. Dr Salpeter has provided expert testimony on a litigation case involving a long-acting β-agonist and was paid on an hourly basis.
Authorship: All authors had access to the data and played a role in writing this manuscript.
PII: S0002-9343(09)01110-3
doi: 10.1016/j.amjmed.2009.07.035
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Medicine
Volume 123, Issue 4
, Pages
322-328.e2
, April 2010

